New pyrrolidinium derivatives having the chemical structure of general formula (I) are disclosed; as well as processes for their preparation, pharmaceutical compositions comprising them and their use in therapy as antagonists of M3 muscarinic receptors.
PYRROLIDINIUM DERIVATIVES AS ANTAGONISTS OF M3 MUSCARINIC RECEPTORS
申请人:Almirall Prodesfarma AG
公开号:EP1497284A2
公开(公告)日:2005-01-19
[EN] NEW PYRROLIDINIUM DERIVATIVES<br/>[FR] NOUVEAUX DERIVES DU PYRROLIDINIUM
申请人:ALMIRALL PRODESFARMA SA
公开号:WO2003087094A2
公开(公告)日:2003-10-23
New pyrrolidinium derivatives having the chemical structure of general formula (I) are disclosed; as well as processes for their preparation, pharmaceutical compositions comprising them and their use in therapy as antagonists of M3 muscarinic receptors.
[EN] PYRROLIDINIUM DERIVATIVES AS ANTAGONISTS OF M3 MUSCARINIC RECEPTORS<br/>[FR] NOUVEAUX DERIVES DU PYRROLIDINIUM
申请人:——
公开号:WO2003087094A3
公开(公告)日:2004-03-18
Pyrrolidinium derivatives
申请人:Prat Quinones Maria
公开号:US20050282875A1
公开(公告)日:2005-12-22
New pyrrolidinium derivatives having the chemical structure of general formula (I)
are disclosed; as well as processes for their preparation, pharmaceutical compositions comprising them and their use in therapy as antagonists of M3 muscarinic receptors.